Pulmonary Fibrosis: all 685 studies
Page 3 of 7. Open to participants first (120), then studies with results posted, then the rest; newest registration first within each.
- The NIH Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients With Interstitial Lung DiseaseCompletedNCT02019641Not applicableResults posted
- Treatment of IPF With Laparoscopic Anti-Reflux SurgeryCompletedNCT01982968Not applicableResults posted
- Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT01979952Phase 3Results posted
- Autoantibody Reduction Therapy in Patients With Idiopathic Pulmonary FibrosisCompletedNCT01969409Phase 2Results posted
- Supplemental Oxygen in Pulmonary FibrosisCompletedNCT01961362Results posted
- Evaluate the Safety and Efficacy of FG-3019 (Pamrevlumab) in Participants With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT01890265Phase 2Results posted
- A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT01872689Phase 2Results posted
- Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF)TerminatedNCT01769196Phase 2Results posted
- Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary FibrosisCompletedNCT01766817Phase 2Results posted
- Long-Term Safety Study of GS-6624 in Adults With Idiopathic Pulmonary Fibrosis (IPF)TerminatedNCT01759511Phase 2Results posted
- A Phase 2, Randomized Dose-ranging Study to Evaluate the Efficacy of Tralokinumab in Adults With Idiopathic Pulmonary FibrosisTerminatedNCT01629667Phase 2Results posted
- Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary FibrosisCompletedNCT01619085Phase 3Results posted
- Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant SuitabilityCompletedNCT01615484Not applicableResults posted
- Clinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary FibrosisCompletedNCT01442779Phase 2Results posted
- Safety and PK Study of BIBF 1120 in Japanese Patients With IPF: Follow up Study From 1199.31(NCT01136174)CompletedNCT01417156Phase 2Results posted
- A Study to Evaluate the Potential Role of Mesenchymal Stem Cells in the Treatment of Idiopathic Pulmonary FibrosisCompletedNCT01385644Phase 1Results posted
- STX-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT01371305Phase 2Results posted
- Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT01366209Phase 3Results posted
- Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients IICompletedNCT01335477Phase 3Results posted
- Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis PatientsCompletedNCT01335464Phase 3Results posted
- Combined PEX, Rituximab and Steroids in Acute Idiopathic Pulmonary Fibrosis ExacerbationsCompletedNCT01266317Phase 1/2Results posted
- A Phase 1b Study of IV PRM151 in Patients With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT01254409Phase 1Results posted
- Study of Inhaled Carbon Monoxide to Treat Idiopathic Pulmonary FibrosisCompletedNCT01214187Phase 2Results posted
- Roll Over Study From 1199.30 BIBF 1120 in Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT01170065Phase 2Results posted
- Safety and PK Study of BIBF 1120 in Japanese Patients With IPFCompletedNCT01136174Phase 2Results posted
- Rehabilitation of Idiopathic Pulmonary Fibrosis (IPF) PatientsCompletedNCT01118221Not applicableResults posted
- Targeting Vascular Reactivity in Idiopathic Pulmonary FibrosisTerminatedNCT00981747Phase 2/3Results posted
- AntiCoagulant Effectiveness in Idiopathic Pulmonary FibrosisTerminatedNCT00957242Phase 3Results posted
- Effect of Lucinactant on Mucus Clearance in Cystic Fibrosis Lung DiseaseCompletedNCT00934362Phase 2Results posted
- Effects of Mycophenolate Mofetil in Cystic Fibrosis Lung Transplant PatientsCompletedNCT00908830Results posted
- Macitentan Use in an Idiopathic Pulmonary Fibrosis Clinical StudyCompletedNCT00903331Phase 2Results posted
- Losartan in Treating Patients With Idiopathic Pulmonary FibrosisCompletedNCT00879879Not applicableResults posted
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary FibrosisTerminatedNCT00879229Phase 3Results posted
- (ARTEMIS-IPF) Randomized, Placebo-Controlled Study to Evaluate Safety and Effectiveness of Ambrisentan in IPFTerminatedNCT00768300Phase 3Results posted
- Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial HypertensionCompletedNCT00705133Phase 2Results posted
- Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary FibrosisTerminatedNCT00703339Phase 2Results posted
- Open-Label Study of the Long Term Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT00662038Phase 3Results posted
- Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPFCompletedNCT00650091Phase 3Results posted
- Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443CompletedNCT00631475Phase 3Results posted
- Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis With ThalidomideCompletedNCT00600028Phase 3Results posted
- Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary FibrosisCompletedNCT00517933Phase 3Results posted
- Safety And Efficacy of BIBF 1120 in Idiopathic Pulmonary FibrosisCompletedNCT00514683Phase 2Results posted
- Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak SyndromeTerminatedNCT00467831Phase 1/2Results posted
- Using Health-related Quality of Life (HRQL) in Routine Clinical CareCompletedNCT00457301Results posted
- BUILD 3: Bosentan Use in Interstitial Lung DiseaseCompletedNCT00391443Phase 3Results posted
- Sildenafil Study to Treat Idiopathic Pulmonary FibrosisCompletedNCT00359736Phase 2Results posted
- Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary FibrosisCompletedNCT00287729Phase 3Results posted
- Three-Arm Study of the Safety and Efficacy of Pirfenidone in Patients With Idiopathic Pulmonary FibrosisCompletedNCT00287716Phase 3Results posted
- EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft RejectionCompletedNCT00105183Phase 3Results posted
- Safety Study of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary FibrosisCompletedNCT00080223Phase 2Results posted
- Scleroderma Lung DiseaseCompletedNCT00004563Phase 3Results posted
- Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak SyndromeCompletedNCT00001596Phase 2Results posted
- Feasibility Randomised Controlled Trial Exploring Implementation of the Compassionate Mindful rEsilience pRogram for People With pUlmonaRY Fibrosis: The MERcURY StudyCompletedNCT07782060Not applicable
- DEVELOPMENT OF INNOVATIVE TARGETED LIPOSOMAL FORMULATIONS FOR THE TREATMENT OF INFLAMMATORY DRIVEN PULMONARY FIBROSISActive, not recruitingNCT07571291
- IPF Longitudinal Natural History StudyActive, not recruitingNCT07560189
- Infusion of Allogeneic Stromal Mesenchymal Stem Cells From Wharton´s Jelly in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement to TreatmentCompletedNCT07542067Phase 1/2
- Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 TrialActive, not recruitingNCT07486206Not applicable
- Clinical Outcomes and Immunotherapy in Lung Cancer With Pulmonary FibrosisActive, not recruitingNCT07396467
- Study on the Drug Interactions of HRS-9813, Pirfenidone and Nintedanib in Healthy SubjectsCompletedNCT07229716Phase 1
- Nasal High-flow Oxygen Therapy During Acute Exercise in Fibrotic Interstitial Lung DiseaseCompletedNCT07129707Not applicable
- Lung Diffusing Capacities Normality Thresholds in Pulmonary Fibrosis and EmphysemaCompletedNCT07091838
- Pulmonary Outcomes on Patients With Lung FibrosisActive, not recruitingNCT07088185Not applicable
- The Effectiveness of Pulmonary Rehabilitation on Saturation in Patients With Idiopathic Pulmonary FibrosisCompletedNCT07031362Not applicable
- Metabolomic Biomarkers Evaluation in Pulmonary FibrosisCompletedNCT06974799
- A Trial of HRS-9813 Capsule and Tablet in Healthy SubjectsCompletedNCT06939504Phase 1
- The BALANCE Study: A Study in Spain to Find Out Whether a Patient Support Program Helps People With Pulmonary Fibrosis Who Take NintedanibCompletedNCT06912659
- A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF10073 After Single and Multiple Doses in Healthy Volunteers and the Effect of Itraconazole on CHF10073 ExposureCompletedNCT06746064Phase 1
- Interstitial Lung Disease Exacerbations StudyActive, not recruitingNCT06685874
- Comparison of the Efficacy of Pirfenidone and Nintedanipine in Pulmonary FibrosisCompletedNCT06650774
- A Study to Evaluate the Safety, Tolerability and Blood Levels of GSK3915393 Administered to Healthy Participants of Chinese, Japanese and European Ancestry and to Assess Effects of GSK3915393 on NintedanibCompletedNCT06625489Phase 1
- Digital Modeling of Thoracic CT and Pulmonary FibrosisActive, not recruitingNCT06618924
- Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed ConditionsCompletedNCT06589921Phase 1
- Comparative Pharmacokinetic(PK) Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed ConditionsCompletedNCT06588517Phase 1
- Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets in Healthy Subjects Under Fasting and Fed ConditionsCompletedNCT06569381Phase 1
- The Assessment of Nutritional Status of Patients With IPFCompletedNCT06563011Not applicable
- Automated Oxygen Titration During Walking in Patients With Lung Fibrosis (OXYWILD)CompletedNCT06465654Not applicable
- Evaluating the Potential of Large Language Models for Respiratory Disease ConsultationsCompletedNCT06457269Not applicable
- Pulmonary Fibrosis After Severe COVID-19 PneumoniaCompletedNCT06423560
- A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)Active, not recruitingNCT06422884Phase 2
- Frequency-time Analysis of Pathological Lung Sounds: Detection and Quantification of Pathological Sounds in Patients With Cystic Fibrosis, Pulmonary Fibrosis or COPD (Chronic Obstructive Pulmonary Disease)TerminatedNCT06399094
- The Effect Of Baduanjin Exercises In Patients With Idiopathic Pulmonary FibrosisCompletedNCT06372353Not applicable
- A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary FibrosisActive, not recruitingNCT06329401Phase 2
- SVF for Treating Pulmonary Fibrosis Post COVID-19CompletedNCT06304623Phase 1
- Effect of Aerobic Exercises Versus Incentive Spirometer Device on Post-covid Pulmonary Fibrosis PatientsActive, not recruitingNCT06191367Not applicable
- Multiple Breath Washout as a Method for Diagnosing Lung DiseasesCompletedNCT06179342
- The Safety, Tolerability, and Pharmacokinetic Study of SC1011 in Healthy Subjects.CompletedNCT06160440Phase 1
- Safety, Tolerability and Pharmacokinetic Study of SC1011 in Healthy SubjectsCompletedNCT06135363Phase 1
- Cardiac Structure and Function in Patients with Cystic FibrosisActive, not recruitingNCT06084468
- AI Assisted Detection of Chest X-RaysCompletedNCT06075836
- Londrina Activities of Daily Living Protocol in Idiopathic Pulmonary Fibrosis PatientsCompletedNCT06049004
- A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary FibrosisActive, not recruitingNCT06025578Phase 3
- A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary FibrosisActive, not recruitingNCT06003426Phase 3
- The First-in-human Study of SRN-001 in Healthy ParticipantsCompletedNCT05984992Phase 1
- Efficacy and Safety of ME-015 (Suplatast Tosilate) in Cough Related to Idiopathic Pulmonary Fibrosis (COSMIC-IPF)Active, not recruitingNCT05983471Phase 2
- 68Ga-FAPI PET/CT to Detect Ongoing Fibroblast Activity in Post-acute COVID-19CompletedNCT05981885
- Safety and Efficacy of Venetoclax in Idiopathic Pulmonary FibrosisCompletedNCT05976217Early Phase 1
- A Study to Investigate Leramistat in Patients With IPFWithdrawnNCT05951296Phase 2
- Clinical Study of Allogeneic Fat Decellularized Active Protein in the Treatment of Pulmonary FibrosisActive, not recruitingNCT05883293Early Phase 1
- A Drug-Drug Interaction Study of ENV-101 (Taladegib) on Nintedanib Pharmacokinetics in Healthy SubjectsCompletedNCT05817240Phase 1
- An In Silico Trial to Evaluate Prospectively the Performance of a Radiomics Algorithm for UIP Compared to Medical DoctorsCompletedNCT05784207